CRON Cronos Group Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CRON

Price (delayed)

$2.07

Market cap

$788.91M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.28

Enterprise value

$218.2M

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology ...

Highlights
Cronos Group's EPS has surged by 53% YoY and by 26% QoQ
The net income has surged by 52% year-on-year and by 25% since the previous quarter
Cronos Group's gross profit has decreased by 44% YoY but it has increased by 10% from the previous quarter
The company's gross margin fell by 40% YoY but it rose by 3.9% QoQ
Cronos Group's equity has decreased by 6% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://thecronosgroup.com

Key stats

What are the main financial stats of CRON
Market
Shares outstanding
381.11M
Market cap
$788.91M
Enterprise value
$218.2M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.7
Price to sales (P/S)
9.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.51
Earnings
Revenue
$86.86M
EBIT
-$125.46M
EBITDA
-$115.9M
Free cash flow
-$85.67M
Per share
EPS
-$0.28
Free cash flow per share
-$0.22
Book value per share
$2.94
Revenue per share
$0.23
TBVPS
$2.95
Balance sheet
Total assets
$1.15B
Total liabilities
$33.35M
Debt
$949,000
Equity
$1.12B
Working capital
$887.8M
Liquidity
Debt to equity
0
Current ratio
30.03
Quick ratio
28.29
Net debt/EBITDA
4.92
Margins
EBITDA margin
-133.4%
Gross margin
10.6%
Net margin
-124.4%
Operating margin
-108.3%
Efficiency
Return on assets
-9.2%
Return on equity
-9.5%
Return on invested capital
-22.1%
Return on capital employed
-11.2%
Return on sales
-144.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CRON stock price

How has the Cronos Group stock price performed over time
Intraday
0%
1 week
5.61%
1 month
8.95%
1 year
-31.68%
YTD
-18.5%
QTD
3.5%

Financial performance

How have Cronos Group's revenue and profit performed over time
Revenue
$86.86M
Gross profit
$9.22M
Operating income
-$94.11M
Net income
-$108.06M
Gross margin
10.6%
Net margin
-124.4%
The company's operating income has surged by 63% YoY and by 6% QoQ
The operating margin has soared by 60% YoY and by 10% QoQ
The net income has surged by 52% year-on-year and by 25% since the previous quarter
The company's net margin rose by 48% YoY and by 28% QoQ

Growth

What is Cronos Group's growth rate over time

Valuation

What is Cronos Group stock price valuation
CRON P/E details
P/E
N/A
P/B
0.7
P/S
9.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.51
Cronos Group's EPS has surged by 53% YoY and by 26% QoQ
The price to book (P/B) is 68% lower than the 5-year quarterly average of 2.2
Cronos Group's equity has decreased by 6% YoY
The price to sales (P/S) is 88% lower than the 5-year quarterly average of 74.7 and 2.4% lower than the last 4 quarters average of 9.3
Cronos Group's revenue has decreased by 6% YoY but it has increased by 5% QoQ

Efficiency

How efficient is Cronos Group business performance
The company's return on invested capital has surged by 55% YoY and by 16% QoQ
CRON's ROE is up by 45% YoY and by 24% QoQ
The company's return on assets rose by 45% YoY and by 23% QoQ
Cronos Group's return on sales has increased by 43% YoY and by 21% QoQ

Dividends

What is CRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CRON.

Financial health

How did Cronos Group financials performed over time
The total liabilities has decreased by 28% YoY but it has increased by 5% QoQ
Cronos Group's current ratio has increased by 18% YoY but it has decreased by 9% from the previous quarter
The company's debt is 100% lower than its equity
The company's debt has shrunk by 50% YoY and by 19% QoQ
Cronos Group's equity has decreased by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.